Alessandra Gennari MD PhD
@ALEDIGNUS12
Followers
890
Following
788
Media
18
Statuses
500
Professor of Oncology @UniAvogadro & Medical Oncologist Head Division of Oncology Maggiore della Carità Hospital Novara IT #BreastCancer #MolecularImaging #IO
Genova, Liguria
Joined June 2019
RT @delmastro_lucia: La preservazione della fertilità è parte essenziale della cura in oncologia. Grazie all’@ass_coscioni per aver dato s….
0
1
0
RT @delmastro_lucia: Onorata di intervenire a #ESCCardioOnco2025. La collaborazione tra diversi specialisti è un esempio concreto di quanto….
0
9
0
RT @M_Tagliamento: Da oggi al 14 con @AIOMtweet @AiomFondazione @AIRC_it @_sirm saremo al Porto Antico del @ComunediGenova per parlare di #….
0
12
0
RT @PTarantinoMD: SERENA6 presentation by Nick Turner. What it shows: that a switch to camizestrant/CDKi vs continuing AI/CDKi can keep pts….
0
1
0
RT @OncoAlert: NEWS FROM INDUSTRY.Source AstraZeneca. The Phase III DESTINY-Breast09 trial marks a significant adv….
0
37
0
RT @myESMO: 📣ESMO Living Guidelines on Metastatic Breast Cancer: .👉Just updated with the latest recommendations and algorithms in an intera….
0
25
0
RT @PTarantinoMD: T-DXd approval finally expanded also in Europe to patients with HR+/HER2-0 (ultralow) disease or chemo-naive pts. Appeali….
0
21
0
RT @DrHBurstein: Important analyses. Thinking about treatment selection by actual prognosis/risk, and not by study eligibility, is a long….
0
15
0
RT @OncoAlert: Our Collaborators at @high5md are here in San Antonio bringing you LIVE Reports from #SABCS24 🇺🇸from TOP international Exper….
0
5
0
RT @Lucarecco: Just released the 2nd version of the @myESMO Essentials for Clinicians - Breast Cancer. Honoured to have contributed w a cha….
0
14
0
RT @OverEventi: Oggi 13 maggio ⌚️ alle ore 14.00.I Laboratori dell’Oncologia di Domani: Molecular Tumor Board.Un Live Webinar con Responsab….
0
2
0
RT @ines_vazluis: Dose/Exposure Relationship of Exercise and Distant Recurrence in Primary Breast Cancer | Journal of Clinical Oncology htt….
ascopubs.org
PURPOSEPostdiagnosis exercise is associated with lower breast cancer (BC) mortality but its link with risk of recurrence is less clear. We investigated the impact and dose-response relationship of...
0
34
0
RT @FedeMiglietta: 🚀Don’t miss out on this must-read review on the role of genomic tests in guiding adjuvant ET for #breastcancer. 🌟Stay a….
0
1
0
0
2
0
RT @OncoAlert: Dear Colleagues,.The @myESMO Presidential Elections are going on.LAST Day to VOTE is June 10th (noon CET) .REMINDER THAT ALL….
0
13
0
RT @OncoAlert: Dear Colleagues .Our friends/Collaborators at@high5md invite you to watch their international experts reporting the TOP in o….
0
4
0
RT @BMJOncology: Transgender individuals face an elevated risk of cancer in comparison with the general population. There is an urgent need….
0
6
0
RT @ErikaHamilton9: #PALMERES-2 🇮🇹 real world efficacy study of 1st L CDK4/6. Ribo & abema showed ⬆️ rwPFS in premeno and luminal B disease….
0
10
0
RT @Prof_Nadia_H: Fantastic #ASCO24 great connecting again. Hope everyone got home safe. See you all at #ESMO in Barcelona #OncoAlert https….
0
3
0